Terms: = Bone cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
131 results:
1. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
[TBL] [Abstract] [Full Text] [Related]
3. AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling.
Ju G; Xing T; Xu M; Zhang X; Sun Y; Mu Z; Sun D; Miao S; Li L; Liang J; Lin Y
Neoplasia; 2024 Mar; 49():100972. PubMed ID: 38237535
[TBL] [Abstract] [Full Text] [Related]
4. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract] [Full Text] [Related]
5. Role of non-coding RNAs as new therapeutic targets in regulating the emt and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract] [Full Text] [Related]
6. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
[TBL] [Abstract] [Full Text] [Related]
7. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast cancer with Focus on Triple-negative Breast cancer.
Naeimzadeh Y; Heidari Z; Razban V; Khajeh S
Curr Mol Pharmacol; 2024; 17(1):e18761429263841. PubMed ID: 37916633
[TBL] [Abstract] [Full Text] [Related]
8. Long non-coding RNA SOX21-AS1: A potential tumor oncogene in human cancers.
Lu Z; Xu J; Cao B; Jin C
Pathol Res Pract; 2023 Sep; 249():154774. PubMed ID: 37633003
[TBL] [Abstract] [Full Text] [Related]
9. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling.
Xia K; Zheng D; Wei Z; Liu W; Guo W
Cell Death Dis; 2023 Aug; 14(8):529. PubMed ID: 37591850
[TBL] [Abstract] [Full Text] [Related]
10. bone morphogenetic protein (BMP)9 in cancer development: mechanistic, diagnostic, and therapeutic approaches?
Alkhathami AG; Abdullah MR; Ahmed M; Hassan Ahmed H; Alwash SW; Muhammed Mahdi Z; Alsaikhan F; Dera AA
J Drug Target; 2023 Aug; 31(7):714-724. PubMed ID: 37461888
[TBL] [Abstract] [Full Text] [Related]
11. VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma.
Yang S; Zhou P; Zhang L; Xie X; Zhang Y; Bo K; Xue J; Zhang W; Liao F; Xu P; Hu Y; Yan R; Liu D; Chang J; Zhou K
Cancer Biol Ther; 2023 Dec; 24(1):2230641. PubMed ID: 37405957
[TBL] [Abstract] [Full Text] [Related]
12. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/emt pathway and associates with clinical prognosis and immune infiltration.
Han GD; Dai J; Hui HX; Zhu J
J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
[TBL] [Abstract] [Full Text] [Related]
13. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract] [Full Text] [Related]
14. LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors
Zhang Q; Tang X; Zhou Y; Chen X; Peng K; Jiang R; Liu Z; Song X; Xia H
Cancer Biol Ther; 2023 Dec; 24(1):2198904. PubMed ID: 37211864
[TBL] [Abstract] [Full Text] [Related]
15. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract] [Full Text] [Related]
16. Identification of an emt-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
PeerJ; 2023; 11():e15013. PubMed ID: 37070095
[TBL] [Abstract] [Full Text] [Related]
18. bone mesenchymal stem cells promote gastric cancer progression through TGF-β1/Smad2 positive feedback loop.
Fan M; Zhang Y; Shi H; Xiang L; Yao H; Lin R
Life Sci; 2023 Jun; 323():121657. PubMed ID: 37019301
[TBL] [Abstract] [Full Text] [Related]
19. Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line.
Hodge MA; Miller T; Weinman MA; Wustefeld-Janssens B; Bracha S; Davis BW
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980828
[TBL] [Abstract] [Full Text] [Related]
20. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract] [Full Text] [Related]
[Next]